Kiniksa Pharmaceuticals
KNSA
KNSA
92 hedge funds and large institutions have $290M invested in Kiniksa Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 37 increasing their positions, 26 reducing their positions, and 9 closing their positions.
Holders
92
Holders Change
-4
Holders Change %
-4.17%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
37
Reduced
26
Closed
9
Calls
$3.32M
Puts
$1.55M
Net Calls
+$1.77M
Net Calls Change
+$1.1M
Top Buyers
| 1 |
RCMNY
1
Rubric Capital Management (New York)
New York
|
$5.07M |
| 2 |
WP
2
Woodline Partners
San Francisco,
California
|
$3.23M |
| 3 |
3
Walleye Capital
New York
|
$2.87M |
| 4 |
4
Morgan Stanley
New York
|
$4.35M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$3.49M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CFGS
101
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
SM
102
SG3 Management
Dorado,
Puerto Rico
| – | – | – | – |
|
103
Parallax Volatility Advisers
San Francisco,
California
| – | – | – | – |
|
104
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
105
Nomura Asset Management
Tokyo,
Japan
| – | – | – | – |
|
|
LC
106
Lindbrook Capital
Calabasas,
California
| $0 | 23 | +23 | New |
|